vs
MADRIGAL PHARMACEUTICALS, INC.（MDGL）与SSR MINING INC.（SSRM）财务数据对比。点击上方公司名可切换其他公司
SSR MINING INC.的季度营收约是MADRIGAL PHARMACEUTICALS, INC.的1.6倍（$521.7M vs $321.1M），SSR MINING INC.净利率更高（34.8% vs -18.2%，领先53.0%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 61.4%），SSR MINING INC.自由现金流更多（$106.4M vs $-133.8M）
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
SSR Mining Inc.（前身为白银标准资源公司）总部位于美国科罗拉多州丹佛，主营金、银、铜、铅、锌矿产开采，拥有阿根廷最大的银矿，同时在美洲全境及土耳其开展矿产勘探业务。2020年与阿拉瑟黄金合并后迁至丹佛，现任总裁兼首席执行官为罗德尼·P·安塔尔。
MDGL vs SSRM — 直观对比
营收规模更大
SSRM
是对方的1.6倍
$321.1M
营收增速更快
MDGL
高出149.3%
61.4%
净利率更高
SSRM
高出53.0%
-18.2%
自由现金流更多
SSRM
多$240.2M
$-133.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $321.1M | $521.7M |
| 净利润 | $-58.6M | $181.5M |
| 毛利率 | — | — |
| 营业利润率 | -18.6% | 38.8% |
| 净利率 | -18.2% | 34.8% |
| 营收同比 | 210.8% | 61.4% |
| 净利润同比 | 1.4% | 3166.6% |
| 每股收益（稀释后） | $-2.55 | $0.84 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDGLSSRM
| Q4 25 | $321.1M | $521.7M | ||
| Q3 25 | $287.3M | $385.8M | ||
| Q2 25 | $212.8M | $405.5M | ||
| Q1 25 | $137.3M | $316.6M | ||
| Q4 24 | $103.3M | $323.2M | ||
| Q3 24 | $62.2M | $257.4M | ||
| Q2 24 | — | $184.8M | ||
| Q1 24 | $0 | $230.2M |
净利润MDGLSSRM
| Q4 25 | $-58.6M | $181.5M | ||
| Q3 25 | $-114.2M | $65.4M | ||
| Q2 25 | $-42.3M | $90.1M | ||
| Q1 25 | $-73.2M | $58.8M | ||
| Q4 24 | $-59.4M | $5.6M | ||
| Q3 24 | $-107.0M | $10.6M | ||
| Q2 24 | — | $9.7M | ||
| Q1 24 | $-147.5M | $-287.1M |
毛利率MDGLSSRM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 96.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率MDGLSSRM
| Q4 25 | -18.6% | 38.8% | ||
| Q3 25 | -39.7% | 21.6% | ||
| Q2 25 | -22.2% | 26.9% | ||
| Q1 25 | -57.8% | 21.1% | ||
| Q4 24 | -64.8% | 10.6% | ||
| Q3 24 | -187.1% | 3.5% | ||
| Q2 24 | — | 5.8% | ||
| Q1 24 | — | -163.5% |
净利率MDGLSSRM
| Q4 25 | -18.2% | 34.8% | ||
| Q3 25 | -39.8% | 17.0% | ||
| Q2 25 | -19.9% | 22.2% | ||
| Q1 25 | -53.4% | 18.6% | ||
| Q4 24 | -57.5% | 1.7% | ||
| Q3 24 | -172.0% | 4.1% | ||
| Q2 24 | — | 5.2% | ||
| Q1 24 | — | -124.7% |
每股收益（稀释后）MDGLSSRM
| Q4 25 | $-2.55 | $0.84 | ||
| Q3 25 | $-5.08 | $0.31 | ||
| Q2 25 | $-1.90 | $0.42 | ||
| Q1 25 | $-3.32 | $0.28 | ||
| Q4 24 | $-2.50 | $0.03 | ||
| Q3 24 | $-4.92 | $0.05 | ||
| Q2 24 | — | $0.05 | ||
| Q1 24 | $-7.38 | $-1.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $198.7M | $575.6M |
| 总债务越低越好 | $339.9M | — |
| 股东权益账面价值 | $602.7M | $3.5B |
| 总资产 | $1.3B | $6.1B |
| 负债/权益比越低杠杆越低 | 0.56× | — |
8季度趋势，按日历期对齐
现金及短期投资MDGLSSRM
| Q4 25 | $198.7M | $575.6M | ||
| Q3 25 | $295.7M | $445.4M | ||
| Q2 25 | $186.2M | $438.5M | ||
| Q1 25 | $183.6M | $341.3M | ||
| Q4 24 | $100.0M | $417.3M | ||
| Q3 24 | $232.7M | $365.8M | ||
| Q2 24 | — | $384.4M | ||
| Q1 24 | $622.5M | $492.0M |
总债务MDGLSSRM
| Q4 25 | $339.9M | — | ||
| Q3 25 | $339.8M | — | ||
| Q2 25 | $118.4M | — | ||
| Q1 25 | $118.0M | — | ||
| Q4 24 | $117.6M | $228.6M | ||
| Q3 24 | $117.1M | $228.3M | ||
| Q2 24 | — | $228.0M | ||
| Q1 24 | $116.1M | $228.7M |
股东权益MDGLSSRM
| Q4 25 | $602.7M | $3.5B | ||
| Q3 25 | $625.7M | $3.3B | ||
| Q2 25 | $696.0M | $3.3B | ||
| Q1 25 | $710.6M | $3.2B | ||
| Q4 24 | $754.4M | $3.1B | ||
| Q3 24 | $777.2M | $3.1B | ||
| Q2 24 | — | $3.1B | ||
| Q1 24 | $850.8M | $3.1B |
总资产MDGLSSRM
| Q4 25 | $1.3B | $6.1B | ||
| Q3 25 | $1.4B | $5.9B | ||
| Q2 25 | $1.0B | $5.8B | ||
| Q1 25 | $996.6M | $5.6B | ||
| Q4 24 | $1.0B | $5.2B | ||
| Q3 24 | $1.1B | $5.1B | ||
| Q2 24 | — | $5.2B | ||
| Q1 24 | $1.1B | $5.3B |
负债/权益比MDGLSSRM
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 0.17× | — | ||
| Q4 24 | 0.16× | 0.07× | ||
| Q3 24 | 0.15× | 0.07× | ||
| Q2 24 | — | 0.07× | ||
| Q1 24 | 0.14× | 0.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-133.5M | $172.1M |
| 自由现金流经营现金流 - 资本支出 | $-133.8M | $106.4M |
| 自由现金流率自由现金流/营收 | -41.7% | 20.4% |
| 资本支出强度资本支出/营收 | 0.1% | 12.6% |
| 现金转化率经营现金流/净利润 | — | 0.95× |
| 过去12个月自由现金流最近4个季度 | — | $241.6M |
8季度趋势，按日历期对齐
经营现金流MDGLSSRM
| Q4 25 | $-133.5M | $172.1M | ||
| Q3 25 | $79.8M | $57.2M | ||
| Q2 25 | $-47.1M | $157.8M | ||
| Q1 25 | $-88.9M | $84.8M | ||
| Q4 24 | $-104.5M | $95.0M | ||
| Q3 24 | $-67.0M | $-1.3M | ||
| Q2 24 | — | $-78.1M | ||
| Q1 24 | $-149.2M | $24.6M |
自由现金流MDGLSSRM
| Q4 25 | $-133.8M | $106.4M | ||
| Q3 25 | $79.0M | $-2.4M | ||
| Q2 25 | — | $98.4M | ||
| Q1 25 | — | $39.3M | ||
| Q4 24 | $-104.7M | $56.4M | ||
| Q3 24 | $-67.8M | $-34.1M | ||
| Q2 24 | — | $-116.3M | ||
| Q1 24 | $-149.5M | $-9.4M |
自由现金流率MDGLSSRM
| Q4 25 | -41.7% | 20.4% | ||
| Q3 25 | 27.5% | -0.6% | ||
| Q2 25 | — | 24.3% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | -101.3% | 17.5% | ||
| Q3 24 | -109.0% | -13.2% | ||
| Q2 24 | — | -62.9% | ||
| Q1 24 | — | -4.1% |
资本支出强度MDGLSSRM
| Q4 25 | 0.1% | 12.6% | ||
| Q3 25 | 0.3% | 15.4% | ||
| Q2 25 | 0.0% | 14.7% | ||
| Q1 25 | 0.0% | 14.4% | ||
| Q4 24 | 0.2% | 11.9% | ||
| Q3 24 | 1.3% | 12.7% | ||
| Q2 24 | — | 20.7% | ||
| Q1 24 | — | 14.8% |
现金转化率MDGLSSRM
| Q4 25 | — | 0.95× | ||
| Q3 25 | — | 0.87× | ||
| Q2 25 | — | 1.75× | ||
| Q1 25 | — | 1.44× | ||
| Q4 24 | — | 17.10× | ||
| Q3 24 | — | -0.13× | ||
| Q2 24 | — | -8.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
SSRM
| Gold | $369.3M | 71% |
| Concentrate Sales | $124.4M | 24% |
| Other | $19.1M | 4% |
| Lead | $9.0M | 2% |
